Filter posts

BIO Accepting Nominations for its Award Honoring One Outstanding Woman in Industrial Biotech

Today, BIO announced that it has officially extended its deadline for the Rosalind Franklin Award for …

Nasdaq Social Bell: Twitter Strategies For Biotechs

Last week at the BIO CEO & Investor Conference in New York City, I had …

Deal Structures: More Options for Companies

By most measures, 2014 was a great year for the biotechnology industry. Venture capital deal …

Ten Years of Therapeutic Venture Capital

What therapeutic areas have received the most funding in private drug companies over the last …

Forbes Asks: Should Economists Perform Surgery and Doctors Conduct Economic Policy?

Over at Forbes, University of Chicago economist Tomas Philipson has an insightful post analyzing several …

Announcing the BIO/Bloomberg Intelligence: 2015 Biotech Industry Outlook Survey

Click here for the BIO/Bloomberg Intelligence: 2015 Biotech Industry Outlook Survey. Your investment plans and …

Exclusive FDA Survey Webinar

BIO is conducting an exciting new survey designed to measure FDA/Sponsor Interactions During Drug Development.  …

The Eyes Have It According to Recent VC Funding Patterns

A recent Wall Street Journal analysis of venture capital investment trends since 1999 reveals which …

Back to School: Consider a STEM Career

With school resuming for many throughout the country this week, one question that may be …

Goodbye, For Now, to our Summer Intern

Summer is winding down. Over the next few weeks, student will be returning to America’s …